BRKR
Ticker
Bruker Corp
Company
LifeSciences
Industry
Healthcare
Sector
Financial Ratio Analysis
+
2009
+
2010
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
β€”17.1%26.6%8.5%2.7%-1.7%-10.2%-0.8%9.6%7.3%9.3%-4.1%21.7%4.7%17.1%13.6%β€”6.1%
Revenue Growth QoQ
β€”17.1%26.6%8.5%2.7%-1.7%-10.2%-0.8%9.6%7.3%9.3%-4.1%21.7%4.7%17.1%13.6%β€”β€”
Gross Margin
46.5%46.3%45.6%46.3%43.8%42.2%43.6%46.1%46.2%47.5%48.0%47.3%50.0%51.6%51.0%49.0%β€”47.2%
EBITDA Margin
14.9%14.7%12.6%12.0%11.4%9.1%12.3%14.4%16.0%17.3%18.2%16.5%20.8%20.6%18.6%13.0%β€”8.1%
Operating Margin
12.3%11.9%9.4%8.7%8.1%5.8%9.0%11.0%12.4%13.8%14.5%12.5%17.1%17.1%14.7%7.5%β€”1.9%
Profit Margin
7.3%7.3%5.6%4.3%4.4%3.1%6.3%9.5%4.5%9.5%9.5%7.9%11.5%11.7%14.4%3.4%β€”-0.6%
FCF / EBITDA
80.2%64.8%12.5%28.0%45.2%48.8%98.0%40.5%39.1%58.2%37.3%71.5%37.9%27.8%44.1%31.1%β€”-3.8%